Sign In
Get Clay Free →

Suggestions

    Roger Estafanos

    Biotech/Pharma Commercial Executive

    Roger Estafanos is a result-driven biopharmaceutical executive with 20 years' experience in strategy development and execution in product launch, commercialization, pricing, and market access.

    He possesses expertise in complex therapeutics and companion diagnostics across various therapeutic areas, notably in oncology and rare diseases, and has a track record of successful P&L management and blockbuster product launches.

    With a background in Certified Pricing Professional (CPP) and executive continuing education from Harvard School of Public Health, Roger holds an MBA in Strategic Management and Marketing from Rutgers Business School.

    His specialties include commercialization, sales & marketing transformation, patient engagement, policy development, business development, strategic planning, pricing strategy, market access, managed markets, managed care, health economics, and management and strategy consultancy.

    In his professional journey, Roger has held positions such as Vice President, Head of Commercial and Access Realization at Novartis, Adjunct Professor at Rutgers Business School, and Member of the Board of Directors at PHI - Quality Care Through Quality Jobs.

    He has also served as Senior Vice President of Payer Strategy at Entree Health, Principal at Peppers & Rogers Group, Managed Markets Area Lead at IBM, and Senior Consultant at CSC and IMS Health.

    Related Questions

    What are Roger Estafanos' main responsibilities at Novartis?
    How did Roger Estafanos transition from ITM to Novartis?
    What are some notable achievements of Roger Estafanos in the biotech industry?
    What is Roger Estafanos' educational background?
    How has Roger Estafanos contributed to advancements in radiopharmaceutical therapy?